Urban, James
Urban, James was paid $4.47M by Medicaid between Jan 2018 and Dec 2024, across 158 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 10.0% of everything it billed.
JOLIET, IL 60435
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 96,689 | $441K | |
| 2019 | 107,957 | $478K | |
| 2020 | 113,974 | $809K | |
| 2021 | 119,385 | $913K | |
| 2022 | 117,288 | $794K | |
| 2023 | 113,220 | $627K | |
| 2024incomplete | 87,622 | $408K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 10.0% | 7,373 | 6,437 | $447K |
| 80053 | Comprehensive metabolic panel | 9.3% | 81,469 | 54,682 | $415K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8.8% | 11,839 | 9,589 | $391K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.0% | 124,660 | 70,326 | $358K |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.6% | 50,751 | 26,876 | $207K |
| 84484 | 3.0% | 28,690 | 21,523 | $133K | |
| 83880 | 2.8% | 11,789 | 9,237 | $124K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.6% | 3,251 | 3,068 | $116K |
| 87040 | 2.5% | 9,236 | 6,963 | $111K | |
| 83735 | 2.3% | 29,322 | 14,262 | $104K | |
| 88341 | 2.3% | 2,054 | 1,833 | $102K | |
| 87641 | 2.3% | 4,616 | 4,072 | $102K |
146 more codes
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.0% | 3,069 | $88K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.7% | 1,518 | $74K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.4% | 2,956 | $65K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.4% | 2,962 | $64K |
| 83690 | 1.4% | 19,021 | $64K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.3% | 448 | $58K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.2% | 2,314 | $56K |
| 83605 | 1.2% | 10,095 | $53K | |
| 88307 | 1.2% | 891 | $52K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.2% | 6,486 | $52K |
| 85730 | 1.1% | 16,056 | $51K | |
| 88342 | 1.0% | 2,568 | $46K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,710 | $42K |
| 81001 | <1% | 28,546 | $41K | |
| 88360 | <1% | 576 | $39K | |
| 85610 | <1% | 20,804 | $39K | |
| 81025 | <1% | 17,372 | $35K | |
| 84703 | <1% | 9,125 | $32K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,918 | $31K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,727 | $29K |
| 80061 | Lipid panel | <1% | 8,431 | $28K |
| 86901 | <1% | 11,979 | $28K | |
| 86850 | <1% | 9,379 | $27K | |
| 84702 | <1% | 5,137 | $22K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 7,125 | $22K |
| 84439 | <1% | 5,098 | $22K | |
| 80076 | <1% | 6,049 | $21K | |
| 87186 | <1% | 3,450 | $21K | |
| 82550 | <1% | 7,416 | $21K | |
| 86900 | <1% | 11,986 | $21K | |
| 84100 | <1% | 9,181 | $21K | |
| 85379 | <1% | 5,522 | $20K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 881 | $20K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 779 | $19K |
| 87486 | <1% | 948 | $19K | |
| 88313 | <1% | 744 | $17K | |
| 82261 | <1% | 2,062 | $17K | |
| 85027 | <1% | 5,842 | $16K | |
| 87581 | <1% | 721 | $16K | |
| 81003 | <1% | 14,147 | $15K | |
| 82607 | <1% | 2,583 | $15K | |
| 83498 | <1% | 2,067 | $15K | |
| 82805 | <1% | 2,476 | $15K | |
| 80202 | <1% | 2,157 | $14K | |
| 82962 | <1% | 6,894 | $14K | |
| 83021 | <1% | 2,076 | $13K | |
| 85060 | <1% | 1,884 | $13K | |
| 82139 | <1% | 2,067 | $12K | |
| 82017 | <1% | 2,044 | $12K | |
| 82140 | <1% | 2,702 | $11K | |
| 82728 | <1% | 2,898 | $11K | |
| 82040 | <1% | 5,043 | $10K | |
| 83655 | <1% | 1,677 | $10K | |
| 87806 | <1% | 991 | $10K | |
| 86769 | <1% | 421 | $9K | |
| 86038 | <1% | 1,120 | $9K | |
| 83540 | <1% | 2,097 | $9K | |
| 86140 | <1% | 3,634 | $8K | |
| 87340 | <1% | 1,273 | $8K | |
| 87070 | <1% | 2,561 | $8K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 386 | $8K |
| 83550 | <1% | 1,800 | $7K | |
| 89125 | <1% | 4,221 | $7K | |
| 86920 | <1% | 1,624 | $7K | |
| 82776 | <1% | 2,061 | $7K | |
| 87081 | <1% | 2,216 | $6K | |
| 82760 | <1% | 2,064 | $6K | |
| 84437 | <1% | 1,986 | $6K | |
| 82565 | <1% | 2,694 | $6K | |
| 82746 | <1% | 1,085 | $6K | |
| 87420 | <1% | 748 | $6K | |
| 82948 | <1% | 3,348 | $6K | |
| 86780 | <1% | 639 | $5K | |
| 82248 | <1% | 2,394 | $5K | |
| 84481 | <1% | 991 | $5K | |
| 82247 | <1% | 2,170 | $5K | |
| 80074 | <1% | 237 | $4K | |
| 87077 | <1% | 840 | $4K | |
| 82784 | <1% | 712 | $4K | |
| 86803 | <1% | 546 | $4K | |
| 85018 | <1% | 3,848 | $4K | |
| 83516 | <1% | 763 | $4K | |
| 84550 | <1% | 2,065 | $4K | |
| 87493 | <1% | 187 | $4K | |
| 87205 | <1% | 2,052 | $4K | |
| 80069 | <1% | 860 | $4K | |
| 83615 | <1% | 1,370 | $3K | |
| 82010 | <1% | 1,486 | $3K | |
| 85652 | <1% | 2,492 | $3K | |
| 85651 | <1% | 1,353 | $3K | |
| 82150 | <1% | 939 | $3K | |
| 86376 | <1% | 652 | $3K | |
| 87797 | <1% | 208 | $3K | |
| 85384 | <1% | 913 | $3K | |
| 87210 | <1% | 1,244 | $3K | |
| 88312 | <1% | 97 | $3K | |
| 88108 | <1% | 152 | $2K | |
| 85014 | <1% | 2,158 | $2K | |
| 87449 | <1% | 284 | $2K | |
| 80164 | <1% | 487 | $2K | |
| 84145 | <1% | 1,546 | $2K | |
| 86706 | <1% | 300 | $2K | |
| 86880 | <1% | 701 | $2K | |
| 84300 | <1% | 928 | $2K | |
| 87075 | <1% | 254 | $2K | |
| 84156 | <1% | 1,289 | $1K | |
| 88189 | <1% | 30 | $1K | |
| 88112 | <1% | 62 | $1K | |
| 84436 | <1% | 434 | $1K | |
| 83930 | <1% | 531 | $1K | |
| 85045 | <1% | 894 | $1K | |
| 84132 | <1% | 526 | $958.40 | |
| 87324 | <1% | 121 | $909.97 | |
| 84155 | <1% | 627 | $791.12 | |
| 82436 | <1% | 343 | $777.53 | |
| 84133 | <1% | 368 | $759.33 | |
| 88304 | <1% | 43 | $734.39 | |
| 85007 | <1% | 400 | $664.15 | |
| 86480 | <1% | 25 | $646.10 | |
| 88720 | <1% | 272 | $595.66 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 17 | $564.38 |
| 86431 | <1% | 152 | $531.34 | |
| 89051 | <1% | 145 | $513.83 | |
| 82330 | <1% | 85 | $465.37 | |
| 88104 | <1% | 56 | $460.92 | |
| 87101 | <1% | 143 | $458.80 | |
| 82300 | <1% | 65 | $435.01 | |
| 86334 | <1% | 30 | $334.80 | |
| 87045 | <1% | 44 | $252.01 | |
| 80500 | <1% | 21 | $244.68 | |
| 82043 | <1% | 124 | $234.08 | |
| 86762 | <1% | 52 | $212.65 | |
| 87660 | <1% | 20 | $175.64 | |
| 82947 | <1% | 94 | $140.17 | |
| 84165 | <1% | 22 | $130.09 | |
| 86255 | <1% | 32 | $112.18 | |
| 87046 | <1% | 47 | $104.10 | |
| 83874 | <1% | 18 | $94.80 | |
| 86870 | <1% | 15 | $93.21 | |
| 83520 | <1% | 13 | $82.42 | |
| 84311 | <1% | 16 | $55.04 | |
| 86592 | <1% | 27 | $54.00 | |
| 83935 | <1% | 20 | $49.95 | |
| 84480 | <1% | 12 | $46.16 | |
| 85347 | <1% | 14 | $39.30 | |
| 84478 | <1% | 31 | $35.63 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.